发明名称 Modified therapeutic peptides with extended half-lives in vivo
摘要 A method for protecting a peptide from peptidase activity in vivo, the peptide being composed of between 2 and 50 amino acids and having a C-terminus and an N-terminus and a C-terminus amino acid and an N-terminus amino acid is described. In the first step of the method, the peptide is modified by attaching a reactive group to the C-terminus amino acid, to the N-terminus amino acid, or to an amino acid located between the N-terminus and the C-terminus, such that the modified peptide is capable of forming a covalent bond in vivo with a reactive functionality on a blood component. In the next step, a covalent bond is formed between the reactive group and a reactive functionality on a blood component to form a peptide-blood component conjugate, thereby protecting said peptide from peptidase activity. The final step of the method involves the analyzing of the stability of the peptide-blood component conjugate to assess the protection of the peptide from peptidase activity.
申请公布号 US2009175821(A1) 申请公布日期 2009.07.09
申请号 US20070982033 申请日期 2007.10.31
申请人 BRIDON DOMINIQUE P;EZRIN ALAN M;MILNER PETER G;HOLMES DARREN L;THIBAUDEAU KAREN 发明人 BRIDON DOMINIQUE P.;EZRIN ALAN M.;MILNER PETER G.;HOLMES DARREN L.;THIBAUDEAU KAREN
分类号 A61K38/38;A61K38/18;A61K38/21;A61K38/22;A61K38/28;C07K19/00 主分类号 A61K38/38
代理机构 代理人
主权项
地址